Thursday, April 18, 2024
4/18/2024
Ribosome biosynthesis is intimately linked to the rates of cell growth and proliferation. Transcription of the ribosomal DNA, mediated by RNA polymerase I (Pol I), is the first, rate- limiting step in ribosome biosynthesis. Based on its critical role in cell biology and its recent emergence as a therapeutic target, the overall goal of this project is to define the mechanisms that control Pol I activity and orchestrate early steps in ribosome biosynthesis. Eukaryotic RNA polymerases have specialized roles, and the three largest ribosomal RNAs are synthesized uniquely by Pol I. There is growing interest in developing Pol I as a therapeutic target for cancer, but to accomplish this goal, we must understand how the enzyme works and how it is regulated. This project will deploy a series of biochemical strategies to define enzymatic properties of Pol I and compare those properties to Pols II and III. The ribosomal DNA locus is densely packed with Pol I transcription elongation complexes, and the kinetics of transcription by these enzymes directly influence processing of the nascent rRNA. Transcription elongation efficiency is influenced by trans-acting transcription elongation factors, DNA template sequence, and metabolic status of the cell. To define how these complex biochemical processes are orchestrated this project will use a blend of genetic, genomic, biochemical and bioinformatic approaches to identify DNA sequences that control Pol I transcription elongation in vitro and in vivo. Many transcription factors that fine tune rRNA expression have been defined. Several of these transcription factors are known to affect Pols I and II, often exhibiting very different effects on the respective enzymes. To understand the principles by which gene expression is regulated there is a need to define the mechanism by which transcription factors function. Pol I is an excellent model enzyme for characterizing transcription factor function in detail. The overall goal of this project, and the Schneider lab as a whole, is to move the field toward mechanistic definition of ribosome biosynthesis. A detailed understanding of this process is fundamentally important to cell biology. Furthermore, there is growing interest in developing selective inhibitors of ribosome biosynthesis, with a focus on Pol I. Thus, there is a critical need for a more complete, mechanistic definition of Pol I function.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
